{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:53:58Z","timestamp":1793044438679,"version":"4.5.0"},"reference-count":267,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5TK6BX005236"],"award-info":[{"award-number":["5TK6BX005236"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["5I01BX000319"],"award-info":[{"award-number":["5I01BX000319"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2020YFC2005000"],"award-info":[{"award-number":["2020YFC2005000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81720108008"],"award-info":[{"award-number":["81720108008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82090024"],"award-info":[{"award-number":["82090024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.pharmthera.2025.108930","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:23:51Z","timestamp":1758939831000},"page":"108930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential"],"prefix":"10.1016","volume":"275","author":[{"given":"Shuangshuang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0005","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1191\/096032799678840255","article-title":"Hyperlipidaemia in cisplatin-induced nephrotic rats","volume":"18","author":"Abdel-Gayoum","year":"1999","journal-title":"Human & Experimental Toxicology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41581-025-00950-5","article-title":"From fat to filter: The effect of adipose tissue-derived signals on kidney function","volume":"21","author":"Ahmed","year":"2025","journal-title":"Nature Reviews Nephrology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0015","series-title":"The role of bioactive lipids in Cancer, inflammation and related diseases","first-page":"169","article-title":"Roles of ceramides and other sphingolipids in immune cell function and inflammation","volume":"Vol. 1161","author":"Albeituni","year":"2019"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5551\/jat.RV17030","article-title":"Diagnosis and Management of Statin Intolerance","volume":"26","author":"Alonso","year":"2019","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1053\/j.ajkd.2004.11.004","article-title":"Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: Results from the diabetes atherosclerosis intervention study (DAIS)","volume":"45","author":"Ansquer","year":"2005","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2016.00573","article-title":"Fatty acid regulation of voltage- and ligand-gated ion channel function","volume":"7","author":"Antollini","year":"2016","journal-title":"Frontiers in Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0035","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.kint.2020.07.027","article-title":"Kidney-derived PCSK9\u2014A new driver of hyperlipidemia in nephrotic syndrome?","volume":"98","author":"Artunc","year":"2020","journal-title":"Kidney International"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/antiox12040883","article-title":"Acute kidney injury induces oxidative stress and hepatic lipid accumulation through AMPK signaling pathway","volume":"12","author":"Au-Yeung","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/360438","article-title":"Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-Hydroxy-2-Nonenal","volume":"2014","author":"Ayala","year":"2014","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","article-title":"Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease","volume":"18","author":"Baek","year":"2022","journal-title":"Nature Reviews Nephrology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0055","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00134-017-4762-8","article-title":"Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury","volume":"43","author":"Bagshaw","year":"2017","journal-title":"Intensive Care Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0060","doi-asserted-by":"crossref","first-page":"R47","DOI":"10.1186\/cc6863","article-title":"Early acute kidney injury and sepsis: A multicentre evaluation","volume":"12","author":"Bagshaw","year":"2008","journal-title":"Critical Care"},{"issue":"10365","key":"10.1016\/j.pharmthera.2025.108930_bb0065","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: Collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"issue":"9784","key":"10.1016\/j.pharmthera.2025.108930_bb0070","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): A randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"The Lancet"},{"issue":"13","key":"10.1016\/j.pharmthera.2025.108930_bb0075","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1042\/CS20200389","article-title":"Potential role of diacylglycerol kinases in immune-mediated diseases","volume":"134","author":"Baldanzi","year":"2020","journal-title":"Clinical Science"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11255-017-1781-x","article-title":"Novel acute kidney injury biomarkers: Their characteristics, utility and concerns","volume":"50","author":"Beker","year":"2018","journal-title":"International Urology and Nephrology"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.2016.0548","article-title":"High-dose perioperative atorvastatin and acute kidney injury following cardiac surgery: A randomized clinical trial","volume":"315","author":"Billings","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.576347","article-title":"Adipocyte ceramides\u2014The Nexus of inflammation and metabolic disease","volume":"11","author":"Chaurasia","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108930_bb0095","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/ki.2011.42","article-title":"The severity of acute kidney injury predicts progression to chronic kidney disease","volume":"79","author":"Chawla","year":"2011","journal-title":"Kidney International"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0100","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ndt\/gfw415","article-title":"The link between phenotype and fatty acid metabolism in advanced chronic kidney disease","volume":"32","author":"Chen","year":"2017","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0105","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1021\/acs.jproteome.6b00956","article-title":"Combined clinical phenotype and Lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism","volume":"16","author":"Chen","year":"2017","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114417","article-title":"Role of sirtuins in metabolic disease-related renal injury","volume":"161","author":"Chen","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"13","key":"10.1016\/j.pharmthera.2025.108930_bb0115","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: A review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41401-021-00660-1","article-title":"Druggability of lipid metabolism modulation against renal fibrosis","volume":"43","author":"Chen","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-024-01277-w","article-title":"Cpd-A1 alleviates acute kidney injury by inhibiting ferroptosis","author":"Chen","year":"2024","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.758311","article-title":"Crosstalk between ER stress, autophagy and inflammation","volume":"8","author":"Chipurupalli","year":"2021","journal-title":"Frontiers in Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0135","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbalip.2016.06.020","article-title":"Oxidized cholesteryl esters and inflammation","volume":"1862","author":"Choi","year":"2017","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0140","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1681\/ASN.2017070802","article-title":"Impairment of PPAR\u03b1 and the fatty acid oxidation pathway aggravates renal fibrosis during aging","volume":"29","author":"Chung","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0145","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: A systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney International"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0150","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2009.03.022","article-title":"Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: An analysis from the collaborative atorvastatin diabetes study (CARDS)","volume":"54","author":"Colhoun","year":"2009","journal-title":"American Journal of Kidney Diseases"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrneph.2016.75","article-title":"Obesity-related glomerulopathy: Clinical and pathologic characteristics and pathogenesis","volume":"12","author":"D\u2019Agati","year":"2016","journal-title":"Nature Reviews. Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/15548627.2023.2252265","article-title":"Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy through SIRT3-mediated TFAM deacetylation","volume":"20","author":"Deng","year":"2024","journal-title":"Autophagy"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102826","article-title":"WBP2 restrains the lysosomal degradation of GPX4 to inhibit ferroptosis in cisplatin-induced acute kidney injury","volume":"65","author":"Deng","year":"2023","journal-title":"Redox Biology"},{"issue":"51","key":"10.1016\/j.pharmthera.2025.108930_bb0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9955","article-title":"Mitochondria form contact sites with the nucleus to couple prosurvival retrograde response","volume":"6","author":"Desai","year":"2020","journal-title":"Science Advances"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0175","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.11.011","article-title":"The nuclear receptor ESRRA protects from kidney disease by coupling metabolism and differentiation","volume":"33","author":"Dhillon","year":"2021","journal-title":"Cell Metabolism"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0180","doi-asserted-by":"crossref","first-page":"602","DOI":"10.7326\/L19-0520","article-title":"Older drugs with limited trial evidence: Are they worth the expense?","volume":"171","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0185","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1194\/jlr.M076745","article-title":"Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury","volume":"58","author":"Dupre","year":"2017","journal-title":"Journal of Lipid Research"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jacl.2018.07.010","article-title":"The CKD plasma lipidome varies with disease severity and outcome","volume":"13","author":"Duranton","year":"2019","journal-title":"Journal of Clinical Lipidology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0195","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3389\/fphys.2018.01494","article-title":"Fibroblast growth factor 23 expression is increased in multiple organs in mice with folic acid-induced acute kidney injury","volume":"9","author":"Egli-Spichtig","year":"2018","journal-title":"Frontiers in Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0200","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.cmet.2012.01.023","article-title":"Saturated fatty acid and TLR signaling link \u03b2 cell dysfunction and islet inflammation","volume":"15","author":"Eguchi","year":"2012","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0205","doi-asserted-by":"crossref","first-page":"F1714","DOI":"10.1152\/ajprenal.00322.2018","article-title":"What we need to know about lipid-associated injury in case of renal ischemia-reperfusion","volume":"315","author":"Erpicum","year":"2018","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.742072","article-title":"Tubular cell glucose metabolism shift during acute and chronic injuries","volume":"8","author":"Faivre","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0220","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrneph.2015.3","article-title":"Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD","volume":"11","author":"Ferenbach","year":"2015","journal-title":"Nature Reviews Nephrology"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108930_bb0225","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41581-018-0072-9","article-title":"Lipid management in patients with chronic kidney disease","volume":"14","author":"Ferro","year":"2018","journal-title":"Nature Reviews Nephrology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0230","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1172\/JCI114651","article-title":"The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans","volume":"85","author":"Fong","year":"1990","journal-title":"Journal of Clinical Investigation"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0235","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/antiox11071356","article-title":"Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease","volume":"11","author":"Fontecha-Barriuso","year":"2022","journal-title":"Antioxidants"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0240","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3390\/biom10020347","article-title":"The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases","volume":"10","author":"Fontecha-Barriuso","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0245","doi-asserted-by":"crossref","first-page":"F1582","DOI":"10.1152\/ajprenal.00385.2019","article-title":"Chronic effects of repeated low-dose cisplatin treatment in mouse kidneys and renal tubular cells","volume":"317","author":"Fu","year":"2019","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0250","doi-asserted-by":"crossref","first-page":"F1098","DOI":"10.1152\/ajprenal.00199.2018","article-title":"Rodent models of AKI-CKD transition","volume":"315","author":"Fu","year":"2018","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.925738","article-title":"P53\/sirtuin 1\/NF-\u03baB signaling Axis in chronic inflammation and maladaptive kidney repair after cisplatin nephrotoxicity","volume":"13","author":"Fu","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108240","article-title":"Inflammation in kidney repair: Mechanism and therapeutic potential","volume":"237","author":"Fu","year":"2022","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0265","doi-asserted-by":"crossref","first-page":"F563","DOI":"10.1152\/ajprenal.00402.2023","article-title":"Rodent models of AKI and AKI-CKD transition: An update in 2024","volume":"326","author":"Fu","year":"2024","journal-title":"American Journal of Physiology. Renal Physiology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.918732","article-title":"Persistent activation of autophagy after cisplatin nephrotoxicity promotes renal fibrosis and chronic kidney disease","volume":"13","author":"Fu","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2013.09.026","article-title":"Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1\/PGC-1\u03b1 activation following ischemia\u2013reperfusion injury","volume":"273","author":"Funk","year":"2013","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108930_bb0280","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202407372","article-title":"Carbon dot nanozymes with ferrous ion-chelating and antioxidative activity inhibiting ferroptosis to alleviate renal ischemia-reperfusion injury","volume":"21","author":"Gao","year":"2025","journal-title":"Small"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0285","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/0886022X.2011.601829","article-title":"Lysophosphatidic acid and lovastatin might protect kidney in renal I\/R injury by downregulating MCP-1 in rat","volume":"33","author":"Gao","year":"2011","journal-title":"Renal Failure"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104215","article-title":"Cardiorenal protection of SGLT2 inhibitors\u2014Perspectives from metabolic reprogramming","volume":"83","author":"Gao","year":"2022","journal-title":"Ebiomedicine"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0295","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.83353","article-title":"Empagliflozin reduces podocyte lipotoxicity in experimental alport syndrome","volume":"12","author":"Ge","year":"2023","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0300","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/sj.emboj.7601633","article-title":"Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1\/PGC-1\u03b1","volume":"26","author":"Gerhart-Hines","year":"2007","journal-title":"The EMBO Journal"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneph.2016.186","article-title":"Metabolic reprogramming and tolerance during sepsis-induced AKI","volume":"13","author":"G\u00f3mez","year":"2017","journal-title":"Nature Reviews Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0310","doi-asserted-by":"crossref","first-page":"5","DOI":"10.29245\/2767-5149\/2020\/2.1108","article-title":"Lysophosphatidic acid prevents ischemia reperfusion injury but does not prevent tubular dysfunction","volume":"2","author":"Gonsalez","year":"2020","journal-title":"Journal of Nephrological Science"},{"issue":"23","key":"10.1016\/j.pharmthera.2025.108930_bb0315","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1161\/CIRCULATIONAHA.105.557652","article-title":"The issue of statin safety: Where do we stand?","volume":"111","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0320","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41581-018-0103-6","article-title":"Epigenetic regulation in AKI and kidney repair: Mechanisms and therapeutic implications","volume":"15","author":"Guo","year":"2019","journal-title":"Nature Reviews Nephrology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0325","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41419-023-05969-9","article-title":"The road from AKI to CKD: Molecular mechanisms and therapeutic targets of Ferroptosis","volume":"14","author":"Guo","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"19","key":"10.1016\/j.pharmthera.2025.108930_bb0330","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.3390\/ijms20194941","article-title":"Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: An updated view","volume":"20","author":"Guzzi","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1681\/ASN.0000000000000291","article-title":"Phosphate restriction prevents metabolic acidosis and curbs rise in FGF23 and mortality in murine folic acid\u2013induced AKI","volume":"35","author":"Hamid","year":"2024","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0340","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2014121181","article-title":"Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism","volume":"27","author":"Han","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102046","article-title":"Acute kidney injury leading to CKD is associated with a persistence of metabolic dysfunction and hypertriglyceridemia","volume":"24","author":"Harzandi","year":"2021","journal-title":"iScience"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108930_bb0350","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138539","article-title":"Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling","volume":"7","author":"Hayakawa","year":"2022","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0355","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0360","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/antiox10030415","article-title":"Generation of reactive oxygen species by mitochondria","volume":"10","author":"Hernansanz-Agust\u00edn","year":"2021","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0365","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.biotechadv.2018.03.003","article-title":"Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR","volume":"36","author":"Hiebl","year":"2018","journal-title":"Biotechnology Advances"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/0886022X.2017.1419974","article-title":"The effect of cholesterol overload on mouse kidney and kidney-derived cells","volume":"40","author":"Honzumi","year":"2018","journal-title":"Renal Failure"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0375","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/ijms21010190","article-title":"Ipragliflozin ameliorates endoplasmic reticulum stress and apoptosis through preventing ectopic lipid deposition in renal tubules","volume":"21","author":"Hosokawa","year":"2019","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb0380","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury","volume":"14","author":"Hoste","year":"2018","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0385","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","article-title":"VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis","volume":"11","author":"Hu","year":"2020","journal-title":"Cell Death & Disease"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb0390","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14078","article-title":"PPAR \u03b1 contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis","volume":"7","author":"Iwaki","year":"2019","journal-title":"Physiological Reports"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0395","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","article-title":"Lipotoxicity as a trigger factor of renal disease","volume":"29","author":"Izquierdo-Lahuerta","year":"2016","journal-title":"Journal of Nephrology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0400","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.kint.2019.08.019","article-title":"Proximal tubule cyclophilin D regulates fatty acid oxidation in cisplatin-induced acute kidney injury","volume":"97","author":"Jang","year":"2020","journal-title":"Kidney International"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0405","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.kint.2018.09.023","article-title":"ATF6\u03b1 downregulation of PPAR\u03b1 promotes lipotoxicity-induced tubulointerstitial fibrosis","volume":"95","author":"Jao","year":"2019","journal-title":"Kidney International"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0410","doi-asserted-by":"crossref","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","article-title":"Mitochondrial dysfunction and the AKI-to-CKD transition","volume":"319","author":"Jiang","year":"2020","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0415","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1111\/j.1523-1755.2005.00325.x","article-title":"Triglyceride accumulation in injured renal tubular cells: Alterations in both synthetic and catabolic pathways","volume":"67","author":"Johnson","year":"2005","journal-title":"Kidney International"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108930_bb0420","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1021\/acs.chemrestox.2c00258","article-title":"Higher concentrations of folic acid cause oxidative stress, acute cytotoxicity, and Long-term Fibrogenic changes in kidney epithelial cells","volume":"35","author":"Kandel","year":"2022","journal-title":"Chemical Research in Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0425","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0430","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13054-020-2752-7","article-title":"Machine learning algorithm to predict mortality in patients undergoing continuous renal replacement therapy","volume":"24","author":"Kang","year":"2020","journal-title":"Critical Care"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0435","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-pathol-050420-025929","article-title":"Lysophospholipid mediators in health and disease","volume":"17","author":"Kano","year":"2022","journal-title":"Annual Review of Pathology: Mechanisms of Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0440","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/ajcn\/47.1.157","article-title":"Hyperlipidemia and the progression of renal disease","volume":"47","author":"Keane","year":"1988","journal-title":"The American Journal of Clinical Nutrition"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102382","article-title":"Farnesoid X receptor protects against cisplatin-induced acute kidney injury by regulating the transcription of ferroptosis-related genes","volume":"54","author":"Kim","year":"2022","journal-title":"Redox Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0450","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00125-012-2747-2","article-title":"Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK\u2013SIRT1\u2013PGC1\u03b1 axis in db\/db mice","volume":"56","author":"Kim","year":"2013","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0455","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000365935","article-title":"Elevated circulating PCSK-9 concentration in renal failure patients is corrected by renal replacement therapy","volume":"40","author":"Konarzewski","year":"2014","journal-title":"American Journal of Nephrology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0460","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011707","article-title":"Sirtuin 3, a new target of PGC-1\u03b1, plays an important role in the suppression of ROS and Mitochondrial biogenesis","volume":"5","author":"Kong","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0465","first-page":"191","article-title":"Safety and tolerability of PCSK9 inhibitors: Current insights","volume":"12","author":"Kosmas","year":"2020","journal-title":"Clinical Pharmacology: Advances and Applications"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0470","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1172\/JCI93560","article-title":"Endoplasmic reticulum stress in the pathogenesis of fibrotic disease","volume":"128","author":"Kropski","year":"2018","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0475","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.09291010","article-title":"Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy","volume":"6","author":"Lachin","year":"2011","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"9887","key":"10.1016\/j.pharmthera.2025.108930_bb0480","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(13)60647-9","article-title":"Acute kidney injury: An increasing global concern","volume":"382","author":"Lameire","year":"2013","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108930_bb0485","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1681\/ASN.2015020177","article-title":"Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI","volume":"27","author":"Lan","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0490","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.2215\/CJN.08070715","article-title":"Long\u2013term renal outcomes after Cisplatin treatment","volume":"11","author":"Latcha","year":"2016","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The key role of altered tubule cell lipid metabolism in kidney disease development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney International"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb0500","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1681\/ASN.2018010050","article-title":"Phosphorylation of acetyl-CoA carboxylase by AMPK reduces renal fibrosis and is essential for the anti-fibrotic effect of metformin","volume":"29","author":"Lee","year":"2018","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0505","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"Journal of Clinical Investigation"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0510","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s42255-020-0238-1","article-title":"Altered proximal tubular cell glucose metabolism during acute kidney injury is associated with mortality","volume":"2","author":"Legouis","year":"2020","journal-title":"Nature Metabolism"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0515","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.153","article-title":"Raising awareness of acute kidney injury: A global perspective of a silent killer","volume":"84","author":"Lewington","year":"2013","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122926","article-title":"Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPAR\u03b1 signaling in renal tubular epithelial cells","volume":"315","author":"Li","year":"2025","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb0525","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1111\/jcmm.15148","article-title":"Sirt3 modulates fatty acid oxidation and attenuates cisplatin-induced AKI in mice","volume":"24","author":"Li","year":"2020","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0530","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.166643","article-title":"Tubular cell senescence promotes maladaptive kidney repair and chronic kidney disease after cisplatin nephrotoxicity","volume":"8","author":"Li","year":"2023","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0535","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ymthe.2024.12.053","article-title":"ATGL regulates renal fibrosis by reprogramming lipid metabolism during the transition from AKI to CKD","volume":"33","author":"Li","year":"2025","journal-title":"Molecular Therapy"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0540","article-title":"VPA improves ferroptosis in tubular epithelial cells after cisplatin-induced acute kidney injury","volume":"14","author":"Li","year":"2023","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0545","doi-asserted-by":"crossref","first-page":"F229","DOI":"10.1152\/ajprenal.00390.2019","article-title":"Evolution of altered tubular metabolism and mitochondrial function in sepsis-associated acute kidney injury","volume":"319","author":"Li","year":"2020","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0550","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/dmrr.874","article-title":"Increased renal collagen cross-linking and lipid accumulation in nephropathy of Zucker diabetic fatty rats","volume":"24","author":"Li","year":"2008","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"15","key":"10.1016\/j.pharmthera.2025.108930_bb0555","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-021-03892-w","article-title":"The role of metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury","volume":"78","author":"Li","year":"2021","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117336","article-title":"UHPLC-MS\/MS-based untargeted lipidomics analysis of septic patients","volume":"544","author":"Liang","year":"2023","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0565","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/15548627.2023.2259732","article-title":"The lipid basis of cell death and autophagy","volume":"20","author":"Lin","year":"2024","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0570","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155974","article-title":"Metabolic reprogramming in septic acute kidney injury: Pathogenesis and therapeutic implications","volume":"158","author":"Liu","year":"2024","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0580","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.7150\/thno.71722","article-title":"Twist1 downregulation of PGC-1\u03b1 decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0585","article-title":"Lipidomics reveals the potential mechanism of honokiol against adenine-induced chronic kidney disease","volume":"13","author":"Liu","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0590","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.toxlet.2024.08.001","article-title":"Identification of serum metabolites associated with aristolochic acid nephropathy severity and insights into the underlying mechanism","volume":"400","author":"Liu","year":"2024","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5828120","article-title":"Mito-TEMPO alleviates renal fibrosis by reducing inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress","volume":"2018","author":"Liu","year":"2018","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0600","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13054-019-2456-z","article-title":"Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors","volume":"23","author":"Liu","year":"2019","journal-title":"Critical Care"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/15548627.2022.2072054","article-title":"Tubular cells produce FGF2 via autophagy after acute kidney injury leading to fibroblast activation and renal fibrosis","volume":"19","author":"Livingston","year":"2023","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0610","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1080\/15548627.2023.2281156","article-title":"Autophagy activates EGR1 via MAPK\/ERK to induce FGF2 in renal tubular cells for fibroblast activation and fibrosis during maladaptive kidney repair","volume":"20","author":"Livingston","year":"2024","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100416","article-title":"Mfsd2a-mediated lysolipid transport is important for renal recovery after acute kidney injury","volume":"64","author":"Loke","year":"2023","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0620","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2022.01.015","article-title":"PCSK9 promotes arterial medial calcification","volume":"346","author":"Lupo","year":"2022","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0625","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2021.10.028","article-title":"Dephosphorylation of AMP-activated protein kinase exacerbates ischemia\/reperfusion-induced acute kidney injury via mitochondrial dysfunction","volume":"101","author":"Ma","year":"2022","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0630","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-022-01090-z","article-title":"ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage","volume":"7","author":"Ma","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0635","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3389\/fphar.2017.00473","article-title":"Lovastatin alleviates endothelial-to-mesenchymal transition in glomeruli via suppression of oxidative stress and TGF-\u03b21 signaling","volume":"8","author":"Ma","year":"2017","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0640","doi-asserted-by":"crossref","DOI":"10.1097\/MNH.0000000000001080","article-title":"Sodium-glucose cotransporter 2 inhibitors: A novel approach to prevent the transition from acute kidney injury to chronic kidney disease","author":"Mart\u00ednez-Rojas","year":"2025","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0645","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/path.5882","article-title":"Ferrostatin-1 modulates dysregulated kidney lipids in acute kidney injury","volume":"257","author":"Mart\u00edn-Saiz","year":"2022","journal-title":"The Journal of Pathology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0650","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.2015121376","article-title":"Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid\u2013Induced AKI","volume":"28","author":"Martin-Sanchez","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"sup1","key":"10.1016\/j.pharmthera.2025.108930_bb0655","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1080\/10715762.2016.1231403","article-title":"Fatty acid-related modulations of membrane fluidity in cells: Detection and implications","volume":"50","author":"Maulucci","year":"2016","journal-title":"Free Radical Research"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0660","doi-asserted-by":"crossref","DOI":"10.1177\/1177271918765137","article-title":"Lipidomic profiling of plasma and erythrocytes from septic patients reveals potential biomarker candidates","volume":"13","author":"Mecatti","year":"2018","journal-title":"Biomarker Insights"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113574","article-title":"Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development","volume":"222","author":"Meduri","year":"2021","journal-title":"European Journal of Medicinal Chemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0670","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/qjmed\/hcx040","article-title":"Meta-analysis of statins in chronic kidney disease: Who benefits? QJM","volume":"110","author":"Messow","year":"2017","journal-title":"Monthly Journal of the Association of Physicians"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0675","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s13105-016-0518-0","article-title":"Increased urinary lysophosphatidic acid in mouse with subtotal nephrectomy: Potential involvement in chronic kidney disease","volume":"72","author":"Mirzoyan","year":"2016","journal-title":"Journal of Physiology and Biochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0680","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s10753-017-0612-7","article-title":"Lysophosphatidic acid protects against endotoxin-induced acute kidney injury","volume":"40","author":"Mirzoyan","year":"2017","journal-title":"Inflammation"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb0685","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0690","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cell.2019.06.017","article-title":"Metabolic and innate immune cues merge into a specific inflammatory response via the UPR","volume":"178","author":"Mogilenko","year":"2019","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb0695","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1194\/jlr.M080465","article-title":"Lipid imaging for visualizing cilastatin amelioration of cisplatin-induced nephrotoxicity","volume":"59","author":"Moreno-Gordaliza","year":"2018","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0700","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.talanta.2016.11.026","article-title":"MALDI-LTQ-Orbitrap mass spectrometry imaging for lipidomic analysis in kidney under cisplatin chemotherapy","volume":"164","author":"Moreno-Gordaliza","year":"2017","journal-title":"Talanta"},{"issue":"22","key":"10.1016\/j.pharmthera.2025.108930_bb0705","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212521","article-title":"Lipidomics reveals cisplatin-induced renal lipid alterations during acute kidney injury and their attenuation by Cilastatin","volume":"22","author":"Moreno-Gordaliza","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0710","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.cmet.2021.04.004","article-title":"KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease","volume":"33","author":"Mori","year":"2021","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0715","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1111\/j.1523-1755.2005.00739.x","article-title":"Fibrate prevents cisplatin-induced proximal tubule cell death","volume":"68","author":"Nagothu","year":"2005","journal-title":"Kidney International"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0720","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1681\/ASN.2007121368","article-title":"Endotoxin mediates recruitment of RNA polymerase II to target genes in acute renal failure","volume":"19","author":"Naito","year":"2008","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0725","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.plipres.2013.12.001","article-title":"Regulation of energy metabolism by long-chain fatty acids","volume":"53","author":"Nakamura","year":"2014","journal-title":"Progress in Lipid Research"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0730","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/ijms22020818","article-title":"Empagliflozin attenuates non-alcoholic fatty liver disease (NAFLD) in high fat diet fed ApoE(\u2212\/\u2212) mice by activating autophagy and reducing ER stress and apoptosis","volume":"22","author":"Nasiri-Ansari","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0735","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41581-021-00423-5","article-title":"Lipoproteins and fatty acids in chronic kidney disease: Molecular and metabolic alterations","volume":"17","author":"Noels","year":"2021","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0740","doi-asserted-by":"crossref","first-page":"F4","DOI":"10.1152\/ajprenal.00275.2023","article-title":"Cell death induced by acute renal injury: A perspective on the contributions of accidental and programmed cell death","volume":"327","author":"Noh","year":"2024","journal-title":"American Journal of Physiology Renal Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0745","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.kint.2016.10.011","article-title":"Pyruvate dehydrogenase kinase 4 deficiency attenuates cisplatin-induced acute kidney injury","volume":"91","author":"Oh","year":"2017","journal-title":"Kidney International"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0750","doi-asserted-by":"crossref","first-page":"F565","DOI":"10.1152\/ajprenal.00023.2003","article-title":"Selective blockade of lysophosphatidic acid LPA3 receptors reduces murine renal ischemia-reperfusion injury","volume":"285","author":"Okusa","year":"2003","journal-title":"American Journal of Physiology Renal Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0755","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nchembio0905-188","article-title":"Cardiolipin oxidation sets cytochrome c free","volume":"1","author":"Orrenius","year":"2005","journal-title":"Nature Chemical Biology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0760","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.kint.2020.04.020","article-title":"Controversies in acute kidney injury: Conclusions from a kidney disease: Improving global outcomes (KDIGO) conference","volume":"98","author":"Ostermann","year":"2020","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0765","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1355674","article-title":"Lipotoxicity and immunometabolism in ischemic acute kidney injury: Current perspectives and future directions","volume":"15","author":"Otunla","year":"2024","journal-title":"Frontiers in Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0770","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1172\/JCI45586","article-title":"Inhibition of PKC\u03b4 reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer","volume":"121","author":"Pabla","year":"2011","journal-title":"Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0775","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: A systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0780","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/ajkd.1998.v31.pm9428473","article-title":"Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats","volume":"31","author":"Park","year":"1998","journal-title":"American Journal of Kidney Diseases"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0785","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney International"},{"issue":"50","key":"10.1016\/j.pharmthera.2025.108930_bb0790","doi-asserted-by":"crossref","first-page":"28510","DOI":"10.1039\/C8RA00488A","article-title":"Protective role of fenofibrate in sepsis-induced acute kidney injury in BALB\/c mice","volume":"8","author":"Pei","year":"2018","journal-title":"RSC Advances"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0795","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41581-024-00806-4","article-title":"Sirtuins in kidney health and disease","volume":"20","author":"Perico","year":"2024","journal-title":"Nature Reviews Nephrology"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0800","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.kint.2021.08.031","article-title":"Loss of proximal tubular transcription factor Kr\u00fcppel-like factor 15 exacerbates kidney injury through loss of fatty acid oxidation","volume":"100","author":"Piret","year":"2021","journal-title":"Kidney International"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108930_bb0805","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1681\/ASN.2007020196","article-title":"LPA1 receptor activation promotes renal interstitial fibrosis","volume":"18","author":"Prad\u00e8re","year":"2007","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0810","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/ijn.IJN_191_17","article-title":"Epidemiology and outcomes of acute kidney injury in critically ill: Experience from a tertiary care center","volume":"28","author":"Priyamvada","year":"2018","journal-title":"Indian Journal of Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0815","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s13054-016-1560-6","article-title":"Perioperative statin therapy in cardiac surgery: A meta-analysis of randomized controlled trials","volume":"20","author":"Putzu","year":"2016","journal-title":"Critical Care (London, England)"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0820","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jare.2023.01.016","article-title":"Ferroptosis in acute kidney injury following crush syndrome: A novel target for treatment","volume":"54","author":"Qiao","year":"2023","journal-title":"Journal of Advanced Research"},{"issue":"16","key":"10.1016\/j.pharmthera.2025.108930_bb0825","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/bph.14935","article-title":"Berberine protects against diabetic kidney disease via promoting PGC-1\u03b1-regulated mitochondrial energy homeostasis","volume":"177","author":"Qin","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0830","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12944-018-0818-1","article-title":"Combination of Chymostatin and Aliskiren attenuates ER stress induced by lipid overload in kidney tubular cells","volume":"17","author":"Qiu","year":"2018","journal-title":"Lipids in Health and Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0835","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1681\/ASN.0000000000000027","article-title":"Hypoxia-inducible factor 2\u03b1 attenuates renal ischemia-reperfusion injury by suppressing CD36-mediated lipid accumulation in dendritic cells in a mouse model","volume":"34","author":"Qu","year":"2023","journal-title":"Journal of the American Society of Nephrology"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb0840","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00100.2016","article-title":"Early lipid changes in acute kidney injury using SWATH lipidomics coupled with MALDI tissue imaging","volume":"310","author":"Rao","year":"2016","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0845","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/ars.2016.6665","article-title":"Oxidant mechanisms in renal injury and disease","volume":"25","author":"Ratliff","year":"2016","journal-title":"Antioxidants & Redox Signaling"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0850","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114465","article-title":"The role of lipotoxicity in kidney disease: From molecular mechanisms to therapeutic prospects","volume":"161","author":"Ren","year":"2023","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0855","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-020-00955-7","article-title":"Evidence that oxidative disbalance and mitochondrial dysfunction are involved in the pathophysiology of fatty acid oxidation disorders","volume":"42","author":"Ribas","year":"2022","journal-title":"Cellular and Molecular Neurobiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108930_bb0860","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161783","article-title":"Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury","volume":"7","author":"Rinaldi","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0865","doi-asserted-by":"crossref","first-page":"449","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and Iron metabolism: Two corner stones in the homeostasis control of Ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0870","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000478","article-title":"Plasma metabolites in early Sepsis identify distinct clusters defined by plasma lipids","volume":"3","author":"Rogers","year":"2021","journal-title":"Critical Care Explorations"},{"issue":"10212","key":"10.1016\/j.pharmthera.2025.108930_bb0875","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute kidney injury","volume":"394","author":"Ronco","year":"2019","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb0880","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1681\/ASN.2006010012","article-title":"Statins for improving renal outcomes: A Meta-analysis","volume":"17","author":"Sandhu","year":"2006","journal-title":"Journal of the American Society of Nephrology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0885","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nature Reviews Nephrology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0890","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/path.5605","article-title":"The dysregulation of metabolic pathways and induction of the pentose phosphate pathway in renal ischaemia\u2013reperfusion injury","volume":"253","author":"Scantlebery","year":"2021","journal-title":"The Journal of Pathology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0895","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1089\/ars.2012.4609","article-title":"Mitochondrial redox signaling: Interaction of mitochondrial reactive oxygen species with other sources of oxidative stress","volume":"20","author":"Schulz","year":"2014","journal-title":"Antioxidants & Redox Signaling"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0900","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s00125-023-06078-0","article-title":"Canagliflozin regulates metabolic reprogramming in diabetic kidney disease by inducing fasting-like and aestivation-like metabolic patterns","volume":"67","author":"Shao","year":"2024","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0905","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/2212796813666190221152908","article-title":"Endogenous repair system of oxidative damage of DNA","volume":"13","author":"Sharma","year":"2019","journal-title":"Current Chemical Biology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0910","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s42255-024-01003-0","article-title":"Futile lipid cycling: From biochemistry to physiology","volume":"6","author":"Sharma","year":"2024","journal-title":"Nature Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb0915","doi-asserted-by":"crossref","first-page":"F560","DOI":"10.1152\/ajprenal.00512.2015","article-title":"Repeated administration of low-dose cisplatin in mice induces fibrosis","volume":"310","author":"Sharp","year":"2016","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0920","doi-asserted-by":"crossref","first-page":"F835","DOI":"10.1152\/ajprenal.00285.2017","article-title":"Developing better mouse models to study cisplatin-induced kidney injury","volume":"313","author":"Sharp","year":"2017","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0925","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1681\/ASN.2015060613","article-title":"\u03b1Klotho mitigates progression of AKI to CKD through activation of autophagy","volume":"27","author":"Shi","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"14","key":"10.1016\/j.pharmthera.2025.108930_bb0930","doi-asserted-by":"crossref","first-page":"13560","DOI":"10.1074\/jbc.M414670200","article-title":"SIRT3, a mitochondrial Sirtuin deacetylase, regulates mitochondrial function and thermogenesis in Brown adipocytes","volume":"280","author":"Shi","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0935","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s10157-012-0621-7","article-title":"Serum levels of soluble secreted \u03b1-klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis","volume":"16","author":"Shimamura","year":"2012","journal-title":"Clinical and Experimental Nephrology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0940","series-title":"Lipophagy: Molecular mechanisms and implications in metabolic disorders","author":"Shin","year":"2020"},{"key":"10.1016\/j.pharmthera.2025.108930_bb0945","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3389\/fimmu.2018.01163","article-title":"Cholesterol crystal-mediated inflammation is driven by plasma membrane destabilization","volume":"9","author":"Shu","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0950","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb0955","first-page":"705","article-title":"Roles of endoplasmic reticulum stress in immune responses","volume":"41","author":"So","year":"2018","journal-title":"Molecules and Cells"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0960","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbrc.2010.10.012","article-title":"Oleate and eicosapentaenoic acid attenuate palmitate-induced inflammation and apoptosis in renal proximal tubular cell","volume":"402","author":"Soumura","year":"2010","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb0965","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.kint.2018.08.037","article-title":"The proteome microenvironment determines the protective effect of preconditioning in cisplatin-induced acute kidney injury","volume":"95","author":"Sp\u00e4th","year":"2019","journal-title":"Kidney International"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb0970","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.toxlet.2013.11.014","article-title":"Suppressed mitochondrial biogenesis in folic acid-induced acute kidney injury and early fibrosis","volume":"224","author":"Stallons","year":"2014","journal-title":"Toxicology Letters"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0975","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb0980","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney International"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb0985","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/ars.2017.7066","article-title":"Lipid deposition in kidney diseases: Interplay among redox, lipid mediators, and renal impairment","volume":"28","author":"Su","year":"2018","journal-title":"Antioxidants & Redox Signaling"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb0990","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCRESAHA.109.196261","article-title":"Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated fatty acid\/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue","volume":"105","author":"Suganami","year":"2009","journal-title":"Circulation Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb0995","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4093\/dmj.2023.0067","article-title":"Dyslipidemia in patients with chronic kidney disease: An updated overview","volume":"47","author":"Suh","year":"2023","journal-title":"Diabetes & Metabolism Journal"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1000","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3389\/fphar.2017.00545","article-title":"Pioglitazone improves mitochondrial function in the remnant kidney and protects against renal fibrosis in 5\/6 Nephrectomized rats","volume":"8","author":"Sun","year":"2017","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb1005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/metabo11020087","article-title":"The effects of SGLT2 inhibitors on lipid metabolism","volume":"11","author":"Szekeres","year":"2021","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1010","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.kint.2016.06.013","article-title":"Protection of mitochondria prevents high-fat diet\u2013induced glomerulopathy and proximal tubular injury","volume":"90","author":"Szeto","year":"2016","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1015","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3389\/fimmu.2020.01346","article-title":"Metabolic flexibility and innate immunity in renal ischemia reperfusion injury: The fine balance between adaptive repair and tissue degeneration","volume":"11","author":"Tammaro","year":"2020","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1020","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","article-title":"Mitochondrial quality control in kidney injury and repair","volume":"17","author":"Tang","year":"2021","journal-title":"Nature Reviews Nephrology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb1025","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1681\/ASN.2015111277","article-title":"Mitochondria in kidney injury: When the Power plant fails","volume":"27","author":"Tang","year":"2016","journal-title":"Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000381510","article-title":"Mitophagy: Basic mechanism and potential role in kidney diseases","volume":"1","author":"Tang","year":"2015","journal-title":"Kidney Diseases"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb1035","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-020-0309-2","article-title":"Autophagy in kidney homeostasis and disease","volume":"16","author":"Tang","year":"2020","journal-title":"Nature Reviews Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","article-title":"Cisplatin nephrotoxicity: New insights and therapeutic implications","volume":"19","author":"Tang","year":"2023","journal-title":"Nature Reviews Nephrology"},{"issue":"3","key":"10.1016\/j.pharmthera.2025.108930_bb1045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.4244\/EIJY15M05_03","article-title":"Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: A meta-analysis of 19 randomised trials","volume":"12","author":"Thompson","year":"2016","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1016\/j.pharmthera.2025.108930_bb1050","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1055","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.8046","article-title":"Oxidative stress as a potential target in acute kidney injury","volume":"7","author":"Tomsa","year":"2019","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASN.0000042803.28024.92","article-title":"Metabolism of cisplatin to a Nephrotoxin in proximal tubule cells","volume":"14","author":"Townsend","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7595","key":"10.1016\/j.pharmthera.2025.108930_bb1065","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1\u03b1 drives NAD biosynthesis linking oxidative metabolism to renal protection","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb1070","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/acs.accounts.5b00056","article-title":"DNA\u2013protein cross-links: Formation, structural identities, and biological outcomes","volume":"48","author":"Tretyakova","year":"2015","journal-title":"Accounts of Chemical Research"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb1075","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-022-00592-x","article-title":"Immunometabolic rewiring of tubular epithelial cells in kidney disease","volume":"18","author":"Van Der Rijt","year":"2022","journal-title":"Nature Reviews Nephrology"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1080","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1021\/acs.analchem.8b05521","article-title":"Rapid identification of ischemic injury in renal tissue by mass-spectrometry imaging","volume":"91","author":"Van Smaalen","year":"2019","journal-title":"Analytical Chemistry"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb1085","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708712","article-title":"Reprogramming of basic metabolic pathways in microbial sepsis: Therapeutic targets at last?","volume":"10","author":"Van Wyngene","year":"2018","journal-title":"EMBO Molecular Medicine"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb1090","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1194\/jlr.M400464-JLR200","article-title":"Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: Role of fatty acid \u03b2-oxidation and glucose","volume":"46","author":"Vankoningsloo","year":"2005","journal-title":"Journal of Lipid Research"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb1095","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1681\/ASN.2015010006","article-title":"Failed tubule recovery, AKI-CKD transition, and kidney disease progression","volume":"26","author":"Venkatachalam","year":"2015","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1100","doi-asserted-by":"crossref","DOI":"10.4172\/jpb.S14-002","article-title":"Targeted Lipidomic and transcriptomic analysis identifies dysregulated renal ceramide metabolism in a mouse model of diabetic kidney disease","volume":"s14","author":"Viji Nair","year":"2015","journal-title":"Journal of Proteomics & Bioinformatics"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1105","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000771","article-title":"CREBH: A complex Array of regulatory mechanisms in nutritional signaling, metabolic inflammation, and metabolic disease","volume":"65","author":"Wade","year":"2021","journal-title":"Molecular Nutrition & Food Research"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb1110","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00375.2015","article-title":"Systemic and renal lipids in kidney disease development and progression","volume":"310","author":"Wahl","year":"2016","journal-title":"American Journal of Physiology. Renal Physiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1115","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/s41401-023-01156-w","article-title":"Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis","volume":"45","author":"Wang","year":"2024","journal-title":"Acta Pharmacologica Sinica"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb1120","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s42255-022-00615-8","article-title":"Analyzing cell-type-specific dynamics of metabolism in kidney repair","volume":"4","author":"Wang","year":"2022","journal-title":"Nature Metabolism"},{"issue":"2","key":"10.1016\/j.pharmthera.2025.108930_bb1125","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/cells9020338","article-title":"Mitophagy in acute kidney injury and kidney repair","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1130","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.kint.2023.08.016","article-title":"Imbalanced lipid homeostasis caused by membrane \u03b1Klotho deficiency contributes to the acute kidney injury to chronic kidney disease transition","volume":"104","author":"Wang","year":"2023","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1135","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2025.02.009","article-title":"Repression of peroxisome proliferation-activated receptor g coactivator-1\u03b1 by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair","author":"Wang","year":"2025","journal-title":"Kidney International"},{"issue":"18","key":"10.1016\/j.pharmthera.2025.108930_bb1140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810880","article-title":"From AKI to CKD: Maladaptive repair and the underlying mechanisms","volume":"23","author":"Wang","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb1145","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-023-06091-6","article-title":"USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA1","volume":"14","author":"Wei","year":"2023","journal-title":"Cell Death & Disease"},{"issue":"9","key":"10.1016\/j.pharmthera.2025.108930_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106647","article-title":"Changes in metabolic profiles during acute kidney injury and recovery following ischemia\/reperfusion","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb1155","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/toxics11060479","article-title":"Lipidomics analysis explores the mechanism of renal injury in rat induced by 3-MCPD","volume":"11","author":"Wei","year":"2023","journal-title":"Toxics"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1160","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cmet.2023.03.018","article-title":"FALCON systematically interrogates free fatty acid biology and identifies a novel mediator of lipotoxicity","volume":"35","author":"Wieder","year":"2023","journal-title":"Cell Metabolism"},{"issue":"6","key":"10.1016\/j.pharmthera.2025.108930_bb1165","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/SHK.0000000000001229","article-title":"Inverse correlation between plasma Sphingosine-1-phosphate and ceramide concentrations in septic patients and their utility in predicting mortality","volume":"51","author":"Wu","year":"2019","journal-title":"Shock"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108930_bb1170","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20192940","article-title":"Metabolomics study of fasudil on cisplatin-induced kidney injury","volume":"39","author":"Xia","year":"2019","journal-title":"Bioscience Reports"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.819787","article-title":"Atorvastatin restores PPAR\u03b1 inhibition of lipid metabolism disorders by downregulating miR-21 expression to improve mitochondrial function and alleviate diabetic nephropathy progression","volume":"13","author":"Xiang","year":"2022","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1180","doi-asserted-by":"crossref","DOI":"10.1093\/burnst\/tkac059","article-title":"Autophagy in acute kidney injury and maladaptive kidney repair","volume":"11","author":"Xiang","year":"2023","journal-title":"Burns & Trauma"},{"issue":"10","key":"10.1016\/j.pharmthera.2025.108930_bb1185","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.7150\/thno.56082","article-title":"Relieving lipid accumulation through UCP1 suppresses the progression of acute kidney injury by promoting the AMPK\/ULK1\/autophagy pathway","volume":"11","author":"Xiong","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155592","article-title":"Regulation of pericyte metabolic reprogramming restricts the AKI to CKD transition","volume":"145","author":"Xu","year":"2023","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1195","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.kint.2022.01.029","article-title":"Nuclear farnesoid X receptor attenuates acute kidney injury through fatty acid oxidation","volume":"101","author":"Xu","year":"2022","journal-title":"Kidney International"},{"issue":"12","key":"10.1016\/j.pharmthera.2025.108930_bb1200","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1681\/ASN.2020050580","article-title":"Spatiotemporal ATP dynamics during AKI predict renal prognosis","volume":"31","author":"Yamamoto","year":"2020","journal-title":"Journal of the American Society of Nephrology"},{"issue":"7","key":"10.1016\/j.pharmthera.2025.108930_bb1205","doi-asserted-by":"crossref","DOI":"10.1080\/15548627.2020.1782034","article-title":"Eicosapentaenoic acid attenuates renal lipotoxicity by restoring autophagic flux","volume":"17","author":"Yamamoto","year":"2021","journal-title":"Autophagy"},{"issue":"5","key":"10.1016\/j.pharmthera.2025.108930_bb1210","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2016070731","article-title":"High-fat diet\u2013induced lysosomal dysfunction and impaired Autophagic flux contribute to lipotoxicity in the kidney","volume":"28","author":"Yamamoto","year":"2017","journal-title":"Journal of the American Society of Nephrology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb1215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/ame2.12194","article-title":"Folic acid-induced animal model of kidney disease","volume":"4","author":"Yan","year":"2021","journal-title":"Animal Models and Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41420-018-0065-2","article-title":"Autophagy activation contributes to lipid accumulation in tubular epithelial cells during kidney fibrosis","volume":"4","author":"Yan","year":"2018","journal-title":"Cell Death Discovery"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1225","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.freeradbiomed.2024.04.213","article-title":"Activation of lipophagy is required for RAB7 to regulate ferroptosis in sepsis-induced acute kidney injury","volume":"218","author":"Yang","year":"2024","journal-title":"Free Radical Biology and Medicine"},{"issue":"8","key":"10.1016\/j.pharmthera.2025.108930_bb1230","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41419-021-04085-w","article-title":"CPT1\u03b1 maintains phenotype of tubules via mitochondrial respiration during kidney injury and repair","volume":"12","author":"Yuan","year":"2021","journal-title":"Cell Death & Disease"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1235","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1523-1755.2000.00154.x","article-title":"Plasma membrane cholesterol: A critical determinant of cellular energetics and tubular resistance to attack","volume":"58","author":"Zager","year":"2000","journal-title":"Kidney International"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1240","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1523-1755.2005.00061.x","article-title":"Renal tubular triglyercide accumulation following endotoxic, toxic, and ischemic injury","volume":"67","author":"Zager","year":"2005","journal-title":"Kidney International"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103593","article-title":"Keap1-independent Nrf2 regulation: A novel therapeutic target for treating kidney disease","volume":"82","author":"Zhang","year":"2025","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1250","article-title":"Forkhead box protein K1 promotes chronic kidney disease by driving glycolysis in tubular epithelial cells","author":"Zhang","year":"2024","journal-title":"Advanced Science"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1255","article-title":"PAFAH2 suppresses synchronized ferroptosis to ameliorate acute kidney injury","author":"Zhang","year":"2024","journal-title":"Nature Chemical Biology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1260","article-title":"A metabolic profiling study of Realgar-induced acute kidney injury in mice","volume":"12","author":"Zhang","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb1265","first-page":"6388","article-title":"Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model","volume":"8","author":"Zhang","year":"2015","journal-title":"International Journal of Clinical and Experimental Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1270","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/metabo12010058","article-title":"Abnormal Iron and lipid metabolism mediated Ferroptosis in kidney diseases and its therapeutic potential","volume":"12","author":"Zhang","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1275","article-title":"Mechanisms and regulations of ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1280","article-title":"The association between serum soluble klotho and chronic kidney disease among us adults ages 40 to 79 years: Cross-sectional study","volume":"10","author":"Zhang","year":"2022","journal-title":"Frontiers in Public Health"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb1285","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.7150\/thno.50905","article-title":"Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance","volume":"11","author":"Zhao","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1290","article-title":"Mitochondrial electron transport chain, ROS generation and uncoupling (review)","author":"Zhao","year":"2019","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156738","article-title":"Diosmin attenuates UUO-induced renal ferroptosis and fibrosis by inhibiting the HIF-1\u03b1\/FABP4 signaling axis","volume":"141","author":"Zhao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1300","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102678","article-title":"Accumulated cholesterol protects tumours from elevated lipid peroxidation in the microenvironment","volume":"62","author":"Zhao","year":"2023","journal-title":"Redox Biology"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1305","series-title":"Renal fibrosis: Mechanisms and therapies","first-page":"557","article-title":"Cell apoptosis and autophagy in renal fibrosis","volume":"Vol. 1165","author":"Zhao","year":"2019"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108930_bb1310","article-title":"Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis and Nrf2 dysfunction in aristolochic acid-induced nephropathy","volume":"5","author":"Zhao","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2023.117616","article-title":"Plasma oxidative lipidomics reveals signatures for sepsis-associated acute kidney injury","volume":"551","author":"Zhou","year":"2023","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155978","article-title":"Cannabinoid receptor 2 plays a key role in renal fibrosis through inhibiting lipid metabolism in renal tubular cells","volume":"159","author":"Zhou","year":"2024","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.pharmthera.2025.108930_bb1325","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.7150\/thno.92848","article-title":"MAGL protects against renal fibrosis through inhibiting tubular cell lipotoxicity","volume":"14","author":"Zhou","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.pharmthera.2025.108930_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155194","article-title":"Transition of acute kidney injury to chronic kidney disease: Role of metabolic reprogramming","volume":"131","author":"Zhu","year":"2022","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.pharmthera.2025.108930_bb1335","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1080\/14728222.2022.2161887","article-title":"Kidney and lipids: Novel potential therapeutic targets for dyslipidemia in kidney disease?","volume":"26","author":"Zuzda","year":"2022","journal-title":"Expert Opinion on Therapeutic Targets"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825001421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825001421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:32:51Z","timestamp":1762248771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825001421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":267,"alternative-id":["S0163725825001421"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108930","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108930"}}